-
-
-
-
-
-
-
Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting
-
-
-
-
-
-
-
Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
-
-
-
-
-
-
-
Solid Biosciences Provides Third Quarter Business Update and Financial Results
-
-
-
-
-
-
-
Solid Biosciences Provides Fourth Quarter and Full-Year 2022 Business Update and Financial Results
-
-
-
-
-
-
-
Solid Biosciences (SLDB) Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement
-
-
-
-
-
-
-
Pre-Open Stock Movers 01/08: (VIH) (GSAT) (CMRX) Higher; (SRPT) (SLDB) (NLTX) Lower (more...)
-
-
-
-
-
-
-
Solid Biosciences (SLDB): Removal of Clinical Hold a 'Clear Positive' - Chardan Capital Markets
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

